Your browser doesn't support javascript.
loading
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer.
Chen, Fang; Jin, Jian-Yue; Hui, Timothy S K; Jing, Haiman; Zhang, Hong; Nong, Yaqing; Han, Ying; Wang, Weili; Ma, Lingyu; Yi, Fan; Chen, Qingqing; Zhang, Yongsheng; Fu, Pingfu; Yang, Li; Xu, Zhiyuan; Kong, Feng-Ming Spring.
Afiliación
  • Chen F; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Jin JY; Department of Clinical Oncology, Hong Kong University Li Ka Shing Medical School, Hong Kong, Hong Kong SAR, China.
  • Hui TSK; Department of Radiation Oncology, Case Western Reserve University, Cleveland, OH, United States.
  • Jing H; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Zhang H; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Nong Y; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States.
  • Han Y; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Wang W; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Ma L; Department of Radiation Oncology, Case Western Reserve University, Cleveland, OH, United States.
  • Yi F; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Chen Q; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Zhang Y; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Fu P; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Yang L; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, United States.
  • Xu Z; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Kong FS; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Front Oncol ; 12: 768956, 2022.
Article en En | MEDLINE | ID: mdl-35600350
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China